• Tomaszewski v. Trevena, Inc.

    Publication Date: 2020-09-14
    Practice Area: Securities Litigation
    Industry: Federal Government | Pharmaceuticals
    Court: U.S. District Court for Pennsylvania - Eastern
    Judge: District Judge Rufe
    Attorneys: For plaintiff:
    for defendant:

    Case Number: 20-1006

    Defendants moved to dismiss plaintiffs §§10(b) and 20(a) of the exchange act and rule 10b-5 class action asserting misrepresentation regarding Food and Drug Administration actions concerning drug company's drug and New Drug Application and court struck confidential minutes of meeting between company and FDA defendants included as part of their motion to dismiss, found complaint sufficiently alleged chief medical officer made a material misrepresentation by omission as to one statement but not as to another and held plaintiffs could pr